Bod Australia has entered into a collaboration agreement with Drug Science UK to assess the efficacy of its MediCabilis product in managing symptoms associated with the long-term impact of Covid-19 (Long Covid).
Long Covid happens when people experience symptoms of Covid-19 and do not fully recover for several weeks or months after the start of their symptoms. The more common symptoms include sleep disturbance, chronic pain, anxiety and fatigue. Currently, there is no treatment.
Bod’s MediCabilis is used to treat conditions including pain and anxiety and the company is confident it may be effective in treating Long Covid.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.